Taken together, these results demonstrate an effective targeting of the myocardium by systemic application of vPMO-AONs and suggest that partial skipping of the mutated exon 326 with restoration of Ttn open reading frame is sufficient to prevent the development of the DCM phenotype in vivo. The gene discussed is TTN; the disease is familial dilated cardiomyopathy.